CN Patent

CN103079544A — 包含丁丙诺啡的可注射的可流动组合物

Assigned to Rb Pharmaceutical Co ltd · Expires 2013-05-01 · 13y expired

What this patent protects

本发明涉及一种能够持续约14天至约3个月递送丁丙诺啡、其代谢产物或其前药的丁丙诺啡缓释递送体系。所述丁丙诺啡缓释递送体系包含用于缓释丁丙诺啡、其代谢产物或其前药的可流动组合物和固体植入物。所述植入物从所述可流动物组合物制得。所述丁丙诺啡缓释递送体系原位提供1个月和3个月的释放曲线，其特征在于极高的生物利用度和最低的永久性组织损伤风险，而且通常没有肌肉坏死的风险。

USPTO Abstract

本发明涉及一种能够持续约14天至约3个月递送丁丙诺啡、其代谢产物或其前药的丁丙诺啡缓释递送体系。所述丁丙诺啡缓释递送体系包含用于缓释丁丙诺啡、其代谢产物或其前药的可流动组合物和固体植入物。所述植入物从所述可流动物组合物制得。所述丁丙诺啡缓释递送体系原位提供1个月和3个月的释放曲线，其特征在于极高的生物利用度和最低的永久性组织损伤风险，而且通常没有肌肉坏死的风险。

Drugs covered by this patent

Patent Metadata

Patent number
CN103079544A
Jurisdiction
CN
Classification
—
Expires
2013-05-01
Drug substance claim
No
Drug product claim
No
Assignee
Rb Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.